Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIMS: Aliskiren + HCTZ in Metabolic Syndrome
NCT00797316Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren, hydrochlorothiazide in hypertension (HTN), sponsored by Novartis. Started Nov 2008; status: completed.
02
Drugs
aliskirenhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00797316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797316.